1. Abelson HT, Garnick MB: Renal failure induced by cancer chemotherapy, in Cancer and the Kidney, edited by Rieselbach RE, Garnick MB, Philadelphia, Lea and Febiger, 1982, p 769
2. Rozencweig M, Von Hoff DD, Slavik M, Muggia FM: Cis-diamminedichloroplatinum (II), a new anticancer drug. Ann Intern Med 86:803–812, 1977
3. Einhorn LH, Williams SD: The role of cis-platinum in solid tumor therapy. N Engl J Med 300:289–291, 1979
4. Schaeppi U, Heyman IA, Fleischman RW, Rosenkrantz H, Ilievski V, Phelan R, Cooney DA, Davis RD: Cis-dichlorodiammine-platinum (II) (NSC-119875): Preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice. Toxicol Appl Pharmacol 25:230–241, 1973
5. Talley RW, O’Bryan RM, Gutterman JU, Brownlee RW, McCredie KB: Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875): Phase I clinical study. Cancer Chemother Rep 57:465–471, 1973